Adolescents and Young Adults With Cancer: Their Preferred Involvement in Decision Making
Launched by STANFORD UNIVERSITY · Jun 15, 2025
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This study is looking at how teenagers and young adults with cancer want to be involved in making decisions about their treatment. Researchers will use short stories, called vignettes, to understand how much these young people want to take part in choosing their care and what factors influence their preferences. The goal is to better support young cancer patients in feeling comfortable and confident about their treatment choices.
If you are between 15 and 29 years old, have been diagnosed with cancer, and are currently receiving treatment, nearing the end of treatment, or have finished treatment within the past year, you might be able to join this study. Participants need to speak and read English and be able to take part without difficulty. If you have certain developmental delays that make participation hard, this study might not be a fit. Being part of the study means you will answer questions and share your thoughts about how you want to make decisions about your care. This can help doctors and families understand what matters most to young people facing cancer.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age (15-29 years)
- • Cancer diagnosis and on therapy, end-of-life or survivors (within 1 year)
- • Speaks English
- • Reads English
- • Cognitively and physically able to participate
- Exclusion Criteria:
- • Unable to participate in study due to developmental delay or developmental disorder
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Palo Alto, California, United States
Patients applied
Trial Officials
Kimberly Pyke-Grimm
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported